{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T20:50:28Z","timestamp":1786395028908,"version":"build-2736575974"},"reference-count":34,"publisher":"The Journal of Rheumatology","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>The diagnostic values of antiproteinase 3 and antimyeloperoxidase tests using antineutrophil cytoplasmic antibodies (ANCA) are well established. Our study determined whether an increase in ANCA level was a predictor of disease flareup.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Our study included 126 patients with ANCA-associated renal vasculitis treated at 9 nephrology centers in Japan. The relationship between increased ANCA levels and relapse was assessed using time-dependent multivariate Cox regression models adjusted for clinically relevant factors. The outcome of interest was the time from remission to first relapse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>During the observation period [median 41 mos, interquartile range (IQR) 23\u201366 mos], 118 patients (95.8%) achieved remission at least once. After achieving remission, 34 patients relapsed (21.7%). Time-dependent multivariate Cox regression models revealed that lung involvement (adjusted HR 2.29, 95% CI 1.13\u20134.65, p = 0.022) and increased ANCA levels (adjusted HR 17.4, 95% CI 8.42\u201336.0, p &lt; 0.001) were significantly associated with relapse. The median time from ANCA level increase to relapse was 0.6 months (IQR 0\u20132.1 mos).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>In our study, an increase in ANCA level during remission was associated with a risk of disease relapse. A rise in ANCA level may be useful for guiding treatment decisions in appropriate subsets of patients with ANCA-associated vasculitis.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.141622","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T01:19:28Z","timestamp":1442366368000},"page":"1853-1860","source":"Crossref","is-referenced-by-count":32,"title":["Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse"],"prefix":"10.3899","volume":"42","author":[{"given":"Makoto","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawako","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotake","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2015,9,15]]},"reference":[{"key":"2018112909351364000_42.10.1853.1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-6-488"},{"key":"2018112909351364000_42.10.1853.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380505"},{"key":"2018112909351364000_42.10.1853.3","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J"},{"key":"2018112909351364000_42.10.1853.4","first-page":"1134","article-title":"Treatment of non-life threatening Wegener\u2019s granulomatosis with methotrexate and daily prednisone as the initial therapy of choice","volume":"26","author":"Stone","year":"1999","journal-title":"J Rheumatol"},{"key":"2018112909351364000_42.10.1853.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.21142"},{"key":"2018112909351364000_42.10.1853.6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-9-200511010-00005"},{"key":"2018112909351364000_42.10.1853.7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.V7133","article-title":"Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Nachman","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"2018112909351364000_42.10.1853.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041884"},{"key":"2018112909351364000_42.10.1853.9","first-page":"467","article-title":"Microscopic polyarteritis: presentation, pathology and prognosis","volume":"56","author":"Savage","year":"1985","journal-title":"Q J Med"},{"key":"2018112909351364000_42.10.1853.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.10459"},{"key":"2018112909351364000_42.10.1853.11","first-page":"448","article-title":"Relapses in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: likely to begin with the same organ as initial onset","volume":"35","author":"Chen","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909351364000_42.10.1853.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.34562"},{"key":"2018112909351364000_42.10.1853.13","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A"},{"key":"2018112909351364000_42.10.1853.14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.057003846.x"},{"key":"2018112909351364000_42.10.1853.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806233182504"},{"key":"2018112909351364000_42.10.1853.16","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.48"},{"key":"2018112909351364000_42.10.1853.17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00821.x"},{"key":"2018112909351364000_42.10.1853.18","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O"},{"key":"2018112909351364000_42.10.1853.19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013111233"},{"key":"2018112909351364000_42.10.1853.20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-9-200711060-00005"},{"key":"2018112909351364000_42.10.1853.21","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200102)44:2<463::AID-ANR65>3.0.CO;2-9"},{"key":"2018112909351364000_42.10.1853.22","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn354"},{"key":"2018112909351364000_42.10.1853.23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.054593"},{"key":"2018112909351364000_42.10.1853.24","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"2018112909351364000_42.10.1853.25","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.062711"},{"key":"2018112909351364000_42.10.1853.26","doi-asserted-by":"publisher","DOI":"10.1186\/ar4550"},{"key":"2018112909351364000_42.10.1853.27","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07300712"},{"key":"2018112909351364000_42.10.1853.28","first-page":"1027","article-title":"A comparative study of the diagnostic accuracy of ELISA systems for the detection of antineutrophil cytoplasm antibodies available in Japan and Europe","volume":"26","author":"Ito-Ihara","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909351364000_42.10.1853.29","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.09.022"},{"key":"2018112909351364000_42.10.1853.30","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92205-V"},{"key":"2018112909351364000_42.10.1853.31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket445"},{"key":"2018112909351364000_42.10.1853.32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.5.572"},{"key":"2018112909351364000_42.10.1853.33","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-1-76"},{"key":"2018112909351364000_42.10.1853.34","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.04.018"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.141622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T22:12:26Z","timestamp":1653171146000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.141622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,15]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,1]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.3899\/jrheum.141622"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.141622","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,15]]}}}